Eris Lifesciences Limited (ERIS) — key facts
NSE-listed · Healthcare. Data as of 11 Nov 2026 (IST) from InvestSights.
Last close: ₹1,255.5 (+0.22% day change)
Key ratios
- P/E ratio
- 27.7
- P/B ratio
- 4.54
- ROE (%)
- 15.87
- ROCE (%)
- 15.9
- Debt/Equity
- 0.6
- Dividend yield (%)
- 0
- Market cap (₹ Cr)
- 17,418.63
Forensic checks
Piotroski F-Score: 5/9 · Altman Z-Score: 6.23 · Beneish M-Score: -1.76
InvestSights quality score
68/100 — Above Average (descriptive data-driven composite; not a recommendation)
Full analysis on InvestSights
InvestSights is an analytics platform and is not SEBI-registered as a Research Analyst or Investment Adviser. All figures are educational, descriptive data — not investment advice. Consult a SEBI-registered adviser before investing.